{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T21:21:00Z","timestamp":1782768060134,"version":"3.54.5"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Autosomal dominant variants in the succinate dehydrogenase gene (SDHx) are responsible for \u223c50% of the development of hereditary paragangliomas and pheochromocytomas (PPGLs). Limited research has been conducted on the psychosocial impact of possessing a hereditary tumor syndrome. In this study, the psychological impact of harboring a genetic variant associated with familial paraganglioma syndrome was assessed. Secondary objectives included the analysis of potential variations in quality of life in (pre)symptomatic stage and comparison with the general Dutch population and other hereditary tumor syndromes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The first 100 patients from the Head and Neck PGL Registry in the University Medical Center Utrecht were selected. Psychosocial outcomes were assessed cross-sectionally using 5 validated health-related questionnaires: EuroQol 5D-5L, Cancer Worry Scale, Hospital Anxiety and Depression Scale, Modified Fatigue Impact Scale, and EORTC QLQ-C30.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>No significant differences were observed when stratified for (pre)symptomatic status or genetic variant status. Hereditary PPGLs tended to express greater concern about the development of PPGLs in family members. Complaints in the physical domains were more frequently observed in the sporadic group. The PPGL cohort demonstrated better outcomes when compared to other hereditary tumor syndromes and aligned with the Dutch tariff.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The psychosocial impact of harboring a PPGL seems to align with the general healthy Dutch population. Clinical care management involving a multidisciplinary approach and comprehensive counseling on PPGLs and their genetic origins, effectively supports patients. Routine psychological support in the care for these patients does not seem imperative and should be offered indicated on a case-by-case basis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf033","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T19:50:56Z","timestamp":1740426656000},"page":"257-265","source":"Crossref","is-referenced-by-count":3,"title":["Low psychosocial burden in patients with paraganglioma syndrome: results from the Head and Neck Paraganglioma Registry in a single center"],"prefix":"10.1093","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5784-2638","authenticated-orcid":false,"given":"Carolijn J M","family":"de Bresser","sequence":"first","affiliation":[{"name":"Department of Vascular Surgery, University Utrecht Medical Center , Heidelberglaan 100, 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A","family":"Rijken","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, University Medical Center Utrecht , Heidelberglaan 100, 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J C","family":"van Treijen","sequence":"additional","affiliation":[{"name":"Department of Endocrine Oncology, University Medical Center Utrecht , Heidelberglaan 100, 3584 CX Utrecht \u00a0","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette P M","family":"van Nesselrooij","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, University Medical Center Utrecht , Heidelberglaan 100, 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mischa","family":"de Ridder","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, University Medical Center Utrecht , Heidelberglaan 100, 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco","family":"de Bree","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgical Oncology, University Medical Center Utrecht , Heidelberglaan 100, 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert J","family":"de Borst","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, University Utrecht Medical Center , Heidelberglaan 100, 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart-Jeroen","family":"Petri","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, University Utrecht Medical Center , Heidelberglaan 100, 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S","family":"van Leeuwaarde","sequence":"additional","affiliation":[{"name":"Department of Endocrine Oncology, University Medical Center Utrecht , Heidelberglaan 100, 3584 CX Utrecht \u00a0","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"issue":"2","key":"2025031114415247100_lvaf033-B1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr Rev"},{"issue":"6","key":"2025031114415247100_lvaf033-B2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","article-title":"Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD","volume":"55","author":"Andrews","year":"2018","journal-title":"J Med Genet"},{"issue":"4","key":"2025031114415247100_lvaf033-B3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2025031114415247100_lvaf033-B4","doi-asserted-by":"publisher","first-page":"e220091","DOI":"10.1530\/eo-22-0091","article-title":"Germline genetic variants in pheochromocytoma\/paraganglioma: single-center experience","volume":"3","author":"Lima","year":"2023","journal-title":"Endocrine Oncol"},{"issue":"12","key":"2025031114415247100_lvaf033-B5","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1038\/s41436-020-0921-3","article-title":"Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome","volume":"22","author":"Greenberg","year":"2020","journal-title":"Genet Med"},{"issue":"S1","key":"2025031114415247100_lvaf033-B6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12881-019-0770-6","article-title":"Novel potential causative genes in carotid paragangliomas","volume":"20","author":"Snezhkina","year":"2019","journal-title":"BMC Med Genet"},{"issue":"2","key":"2025031114415247100_lvaf033-B7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Favier","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2025031114415247100_lvaf033-B8","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025031114415247100_lvaf033-B9","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","volume":"174","author":"Plouin","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2025031114415247100_lvaf033-B10","doi-asserted-by":"publisher","first-page":"986","DOI":"10.3390\/cancers16050986","article-title":"The additional value of somatostatin receptor positron emission computed tomography ([68Ga]Ga-DOTATOC PET\/CT) compared with magnetic resonance imaging of the head and neck region in paraganglioma patients: a pilot study","volume":"16","author":"de Bresser","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2025031114415247100_lvaf033-B11","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1210\/jc.2018-00259","article-title":"High fear of disease occurrence is associated with low quality of life in patients with multiple endocrine neoplasia type 1: results from the Dutch MEN1 study group","volume":"103","author":"Van Leeuwaarde","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025031114415247100_lvaf033-B12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1399-0004.2009.01333","article-title":"Psychosocial impact of Von Hippel-Lindau disease: levels and sources of distress","volume":"77","author":"Lammens","year":"2010","journal-title":"Clin Genet"},{"issue":"5","key":"2025031114415247100_lvaf033-B13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1530\/EJE-12-0968","article-title":"Quality of life is decreased in patients with paragangliomas","volume":"168","author":"Van Hulsteijn","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025031114415247100_lvaf033-B14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1530\/EJE-07-0464","article-title":"Reduced quality of life in patients with head-and-neck paragangliomas","volume":"158","author":"Havekes","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2025031114415247100_lvaf033-B15"},{"issue":"1","key":"2025031114415247100_lvaf033-B16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1530\/eje.1.01833","article-title":"Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas","volume":"152","author":"van Houtum","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025031114415247100_lvaf033-B17","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/hex.13254","article-title":"Patient-reported outcome measures (PROMs): a review of generic and condition-specific measures and a discussion of trends and issues","volume":"24","author":"Churruca","year":"2021","journal-title":"Health Expect"},{"issue":"7","key":"2025031114415247100_lvaf033-B18","doi-asserted-by":"publisher","first-page":"e0307311","DOI":"10.1371\/journal.pone.0307311","article-title":"Head and Neck Paraganglioma (HNPGL) Registry: a study protocol for prospective data collection in patients with Head and Neck Paragangliomas","volume":"19","author":"de Bresser","year":"2024","journal-title":"PLoS One"},{"issue":"20","key":"2025031114415247100_lvaf033-B19","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"6","key":"2025031114415247100_lvaf033-B20","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s11165-016-9602-2","article-title":"The use of Cronbach\u2019s alpha when developing and reporting research instruments in science education","volume":"48","author":"Taber","year":"2018","journal-title":"Res Sci Educ"},{"issue":"2","key":"2025031114415247100_lvaf033-B21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1547-5069.2007.00161.x","article-title":"A psychometric toolbox for testing validity and reliability","volume":"39","author":"Devon","year":"2007","journal-title":"J Nurs Scholarsh"},{"key":"2025031114415247100_lvaf033-B22","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-89289-0","volume-title":"Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide","author":"Devlin","year":"2022"},{"key":"2025031114415247100_lvaf033-B23","author":"Van Reenen"},{"issue":"1","key":"2025031114415247100_lvaf033-B24","doi-asserted-by":"publisher","first-page":"E44","DOI":"10.1097\/NCC.0b013e3182813a17","article-title":"The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors","volume":"37","author":"Custers","year":"2014","journal-title":"Cancer Nurs"},{"issue":"1","key":"2025031114415247100_lvaf033-B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-3956(89)90013-7","article-title":"Problems with the differentiation of anxiety and depression","volume":"23","author":"Wetzler","year":"1989","journal-title":"J Psychiat Res"},{"issue":"3","key":"2025031114415247100_lvaf033-B26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jpsychores.2011.06.008","article-title":"Latent structure of the Hospital Anxiety and Depression Scale: a 10-year systematic review","volume":"72","author":"Theodore","year":"2012","journal-title":"J Psychosom Res"},{"key":"2025031114415247100_lvaf033-B27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume-title":"Acta Psychiatr Scand","author":"Zigmond","year":"1983"},{"key":"2025031114415247100_lvaf033-B28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-94-007-7596-1_3","volume-title":"Self-Reported Population Health: An International Perspective Based on EQ-5D","author":"Janssen","year":"2014"},{"key":"2025031114415247100_lvaf033-B29","volume-title":"Quality of Life in Patients with Multiple Endocrine Neoplasia Type 1 (MEN1)","author":"Berglund","year":"2003"},{"key":"2025031114415247100_lvaf033-B30","doi-asserted-by":"publisher","first-page":"1318584","DOI":"10.3389\/fpsyg.2024.1318584","article-title":"Quality-of-life among women with breast cancer: application of the international classification of functioning, disability and health model","volume":"15","author":"Al-Sharman","year":"2024","journal-title":"Front Psychol"},{"key":"2025031114415247100_lvaf033-B31","volume-title":"EORTC QLQ-C30 Reference Values This Manual Presents Reference Data for the QLQ-C30 Based upon Data Provided by EORTC Quality of Life Group Members and Other Users of the QLQ-C30 Sprangers on Behalf of the EORTC","author":"Scott","year":"2008"},{"issue":"9","key":"2025031114415247100_lvaf033-B32","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1007\/s11136-023-03404-2","article-title":"Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study","volume":"32","author":"de Ligt","year":"2023","journal-title":"Qual Life Res"},{"issue":"1","key":"2025031114415247100_lvaf033-B33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12105-022-01414-z","article-title":"Update from the 5th Edition of the World Health Organization classification of head and neck tumors: familial tumor syndromes","volume":"16","author":"Nos\u00e9","year":"2022","journal-title":"Head Neck Pathol"},{"issue":"3","key":"2025031114415247100_lvaf033-B34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11764-013-0272-z","article-title":"Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies","volume":"7","author":"Simard","year":"2013","journal-title":"J Cancer Surviv"},{"issue":"8","key":"2025031114415247100_lvaf033-B35","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s00520-016-3272-5","article-title":"From normal response to clinical problem: definition and clinical features of fear of cancer recurrence","volume":"24","author":"Lebel","year":"2016","journal-title":"Support Care Cancer"},{"key":"2025031114415247100_lvaf033-B36","author":"Neumann"},{"issue":"1","key":"2025031114415247100_lvaf033-B37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/cge.13055","article-title":"The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers","volume":"93","author":"Rijken","year":"2018","journal-title":"Clin Genet"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf033\/62113922\/lvaf033.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/3\/257\/62113922\/lvaf033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/3\/257\/62113922\/lvaf033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T15:07:22Z","timestamp":1741705642000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/192\/3\/257\/8038114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf033","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,2,24]]}}}